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performed at the bedside or in the out-patient clinic is
needed to better deﬁne the correct interpretation of TE
individual data. Indeed, these frequent or rare diseases
may be occasionally encountered in patients with hepa-
titis (B, C, auto immune), HIV infection, NASH, iron
overload or alcohol-related disorders.
Our observation underscores the inherent challenges
to pathologic diagnosis or even the limited assessment
of ﬁbrosis or cirrhosis using a surrogate biochemical
or indirect physical measurements; no alternative alone
can or should be translated literally into the more com-
plex designation of cirrhosis, and neither should the term
ﬁbrosis be used synonymously with cirrhosis [5]. So far
there is now clinical evidence that TE does not measure
ﬁbrosis exclusively (for review see 2).
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To the Editor:
We thank Dr. Bioulac-Sage and colleagues for their
interest in our review. The case of cardiac hepatopathy
they report emphasizes the fact that interpretation of
the results of transient elastography (TE) and other
non-invasive tests should always be done by expert clini-
cians according to the clinical context. Indeed, although
the clinical and biological features of this patient could
be consistent with the diagnosis of cirrhosis related to
NASH, the patient had a past history of severe cardiac
disease (myocardial infarction, triple coronary bypasses,
and an implantable cardioverter–deﬁbrillator). No
information regarding physical examination or ultraso-
nography is provided by the authors. The presence of
enlarged liver and/or hepato-jugular reﬂux on physical
examination together with dilated hepatic veins and
inferior vena cava, suggestive of chronic heart failure,
would have helped to anticipate the ﬁndings of liver
biopsy. Although we believe that combining TE with
serum non-invasive markers such as Fibrotest increases
diagnostic accuracy, we emphasize that so far, it has
only been studied in patients with hepatitis C [1]. The
discrepancy between the two TE results is surprising
within such a short period of time (2 months): ‘‘quality
criteria” (interquartile range (IQR) and success rate) for
interpretation of TE results are not provided by the
authors but measurements are said to be satisfactory.
Although TE has been shown to be a reproducible tech-
nique, longitudinal data are still lacking. Preliminary
results regarding liver stiﬀness dynamics in a control
group of untreated patients with chronic hepatitis C sug-
gest that liver stiﬀness values are stable over time [2].
Thus, this discrepancy remains diﬃcult to explain.
As stressed by the authors, it is likely that perisinuos-
idal ﬁbrosis contributed to the increased liver stiﬀness
values. As suggested by morphometric studies [3], liver
stiﬀness seems to accurately reﬂect the amount of liver
ﬁbrosis whatever its location and inﬂuence on liver
architecture. Consistent with this ﬁnding, marked peris-
inusoidal ﬁbrosis was reported in 10 out of 45 patients
without cirrhosis but with increased liver stiﬀness values
suggestive of cirrhosis (>14.6 kPa) [4]. Also, a good cor-
relation between liver stiﬀness values and the degree of
perisinusoidal ﬁbrosis has been shown in a recent study
in alcoholic patients in whom perisinusoidal ﬁbrosis is
common [5]. However, in multivariate analysis, liver
stiﬀness values were only correlated with Metavir Fibro-
sis score. Apart from ﬁbrosis, other parameters such as
necro-inﬂammatory activity may also inﬂuence liver
stiﬀness measurements [6], but the reported patient
had normal transaminase levels and no inﬂammation
on liver biopsy. Finally, the inﬂuence of architectural
disturbances such as sinusoidal dilatation on liver stiﬀ-
ness measurements remains unknown. More data are
awaited on that speciﬁc issue in patients with sinusoidal
and vascular diseases.
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